Pancreatic Cancer Research

ResearcherHallym UniversityActive in the last 2 years

Sung‐Hoon Moon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7879-3114; OpenAlex author ID A5004001889. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 9

  1. Chemotherapy for Older Adults with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/jcm15062254↗
  2. Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicen… Co-author DOI 10.1016/j.ejca.2024.114194↗
  3. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis. Co-author DOI 10.1007/s00330-023-09959-5↗
  4. A multidisciplinary approach is essential for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma. Co-author DOI 10.5946/ce.2023.116↗
  5. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma. Co-author DOI 10.1007/s00330-022-08816-1↗
  6. ADC values from diffusion-weighted imaging may be lower for autoimmune pancreatitis than for pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.dld.2022.04.003↗
  7. Immunotherapy for pancreatic cancer. Last author DOI 10.12998/wjcc.v9.i13.2969↗
  8. Contrast-Enhanced Endoscopic Ultrasound for Differentially Diagnosing Autoimmune Pancreatitis and Pancreatic Cancer. First author DOI 10.5009/gnl17391↗
  9. Diagnostic Strategy for Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Is an Endoscopic Retrograde Pancreatography Essential? Last author DOI 10.1097/mpa.0b013e31823a509b↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tae Yeon Jeon · 3 shared papers, 2022–2023 · strength 0.66
  2. Seung Bae Yoon · 3 shared papers, 2022–2023 · strength 0.66
  3. Dong Woo Shin · 2 shared papers, 2023–2026 · strength 0.58
  4. Sang Min Lee · 2 shared papers, 2022–2023 · strength 0.40
  5. Jong-Chan Lee · 1 shared paper, 2026 · strength 0.39
  6. Myung‐Hwan Kim · 3 shared papers, 2012–2022 · strength 0.31
  7. Do Hyun Park · 3 shared papers, 2012–2024 · strength 0.29
  8. Tae Jun Song · 2 shared papers, 2018–2024 · strength 0.26
  9. Dongwook Oh · 2 shared papers, 2018–2024 · strength 0.26
  10. Jai Hoon Yoon · 1 shared paper, 2021 · strength 0.22
  11. Moon Hyung Choi · 1 shared paper, 2023 · strength 0.19
  12. Min-Jeong Kim · 1 shared paper, 2023 · strength 0.19
  13. Ji Hye Min · 1 shared paper, 2023 · strength 0.19
  14. Zev A. Wainberg · 1 shared paper, 2024 · strength 0.18
  15. Choong‐kun Lee · 1 shared paper, 2024 · strength 0.18
  16. Hye Jin Choi · 1 shared paper, 2024 · strength 0.18
  17. Hyehyun Jeong · 1 shared paper, 2024 · strength 0.18
  18. Kyu‐pyo Kim · 1 shared paper, 2024 · strength 0.18
  19. Dae Young Zang · 1 shared paper, 2024 · strength 0.18
  20. Inkeun Park · 1 shared paper, 2024 · strength 0.18
  21. Baek‐Yeol Ryoo · 1 shared paper, 2024 · strength 0.18
  22. Changhoon Yoo · 1 shared paper, 2024 · strength 0.18
  23. Min Keun Cho · 1 shared paper, 2018 · strength 0.08
  24. Dong Wan Seo · 1 shared paper, 2018 · strength 0.08
  25. Sang Soo Lee · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.